Drug Screening Market Size, Share and Global Trend By Product (Analytical Instruments, Rapid Testing Devices, Consumables), By Sample Type (Urine, Breath, Oral Fluids, Others), By End User (Hospitals, Workplace, Criminal Justice) and Regional Forecast, 2024-2032

Drug screening is the process of recognizing illicit and some recommended drugs in the blood, urine, and other biological samples. A drug screening process is also referred as analysis and detection of performance-enhancing drugs consumed by professional athletes such as steroids and HGH in order to improve stamina and performance during the sport.

Some of the major illegal drugs include heroin, cannabis, cocaine, methamphetamines, methadone, and amphetamine. Increasing incidence of such drugs consumptions across the globe is the major concern being faced by many governments. For instance, according to National Institute on Drug Abuse (NIDA), in 2010, an estimated 22.6 million of the population was illicit drug users in the U.S, which accounted for an estimated 8.9% of the total population of the country.

Increasing prevalence of drugs addiction and illicit drug consumption is expected to drive the growth of the global drug screening market during the forecast period. Moreover, increasing crime rates associated with drug abuse are projected to increase the adoption of drug screening, which is anticipated to fuel the growth of the global drug screening market.

However, stringent government regulations are expected to hamper the growth of the global drug screening market by 2026. Moreover, the lack of infrastructure in emerging nations is projected to restrain the growth of the global drug screening market during the forecast period.

Key Players Covered

Some of the major companies operating in the global drug screening market are Alere, Thermo Fisher Scientific, Drägerwerk, Laboratory Corporation of America Holdings, Quest Diagnostics, Alfa Scientific Designs, Lifeloc, MPD Inc., Orasure and others.

SEGMENTATION

Among the segmentation, rapid testing devices in the product segment is anticipated to hold a considerable share of the market owing to increasing demand for faster diagnostic processes.

Key Insights

• The regulatory scenario for key countries


• New product introduction


• Prevalence of drug abuse for key countries


• Recent industry developments such as partnerships, mergers, and acquisitions

Regional Analysis

Among the region, North America is expected to dominate the global drug screening market during the forecast period. Certain factors such as the increasing number of drug and alcohol abuse cases and enforcement of stringent laws. New organ-on-a-chip platforms allow better and accurate perception into the possible effects of drugs on the human body. Organ-on-a-chip innovations are also adding up to the growth of the North America drug screening market. Asia Pacific is expected to exhibit significant CAGR in the forecast period, with China and India being the fastest-growing market. A growing number of drug addicts, development of advanced drug and alcohol screening devices, growing awareness regarding the significance of alcohol and drug screening, and rise in initiatives taken by the government and private institutes towards the drug detection system are projected to play a significant role in the growth of the drug screening market in the Asia Pacific.

Key Industry Developments

• In August 2018, Drager Safety Canada got government approval for its Dräger DrugTest 5000 drug testing device, Canada’s first roadside oral fluid drug testing with active government support. 
• In September 2018, Alcohol Countermeasure Systems Corp. launched WipeAlyser, a portable drug screening test
• In August 2017, Intelligent Fingerprinting Limited, an U.K. based company launched world’s first portable fingerprint drug test for detection and analysis of cocaine, opiates, cannabis and amphetamines. The newly launched device enables collection and analysis of sample in just 10 minutes making the process quicker.